Experience with long-term infliximab therapy in patients with ankylosing spondylitis

Experience with long-term infliximab therapy in patients with ankylosing spondylitis

The duration of continuous use of infliximab is more than 8 years in patients with ankylosing spondylitis (AS). The efficiency of the drug persists in most patients during its long-term regular therapy. Objective. To evaluate the effectiveness and safety of long-term infliximab therapy in patients w...

Full description

Saved in:
Bibliographic Details
Main Authors: Oksana Alekseevna Rumyantseva, A G Bochkova, K Kh Kuzikyants, A V Levshakova, Sh F Erdes, E L Nasonov, Oksana Alekseyevna Rumyantseva
Format: Article
Language:Russian
Published: IMA PRESS LLC 2010-12-01
Series:Научно-практическая ревматология
Subjects:
infliximab
ankylosing spondylitis
sacroiliitis
enthesitis
remission
Online Access:https://rsp.mediar-press.net/rsp/article/view/951
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://rsp.mediar-press.net/rsp/article/view/951

Similar Items